T1	Procedure 11 20	treatment
T2	Temporal 28 45	two weeks or more
R1	Has_temporal Arg1:T1 Arg2:T2	
T4	Condition 511 529	Cushing's syndrome
T5	Condition 531 548	Addison's disease
T6	Condition 550 574	diabetes mellitus type 1
T7	Condition 576 585	leukaemia
T8	Condition 587 605	pernicious anaemia
T9	Condition 607 630	malabsorption syndromes
T10	Condition 632 653	chronic liver disease
T11	Condition 655 675	rheumatoid arthritis
*	OR T11 T10 T9 T8 T7 T6 T5 T4
T3	Drug 214 231	immunosuppressive
T12	Drug 191 203	cyclosporine
T13	Drug 170 189	calcium antagonists
T14	Drug 153 168	anti-epileptics
T15	Condition 122 142	gingival hypertrophy
*	OR T14 T13 T12 T3
T16	Scope 153 231	anti-epileptics, calcium antagonists, cyclosporine and other immunosuppressive
R2	Has_scope Arg1:T15 Arg2:T16	
T17	Observation 236 251	bone metabolism
T18	Drug 258 271	anticoagulant
T19	Drug 299 306	steroid
T20	Multiplier 325 344;361 366	equal or more 2.5mg a day
T21	Drug 348 360	prednisolone
R3	Has_multiplier Arg1:T21 Arg2:T20	
T22	Temporal 377 386	>3 months
R4	Has_temporal Arg1:T21 Arg2:T22	
T23	Drug 390 405	anticonvulsants
T24	Drug 407 425	immunosuppressants
*	OR T15 T17
*	OR T18 T19 T21 T23 T24
T25	Scope 258 426	anticoagulant medications, long-standing steroid medications -i.e. equal or more 2.5mg of prednisolone a day taken for >3 months -, anticonvulsants, immunosuppressants)
R5	Subsumes Arg1:T17 Arg2:T25	
T26	Condition 708 717	Hepatitis
T27	Condition 701 704	HIV
*	OR T26 T27
T28	Procedure 731 754	local radiation therapy
T29	Temporal 762 777	last five years
R6	Has_temporal Arg1:T28 Arg2:T29	
T30	Post-eligibility 781 963	ffected by limited mental capacity or language skills such that study information cannot be understood, informed consent cannot be obtained, or simple instructions cannot be followed
T31	Condition 997 1015	periodontal lesion
T32	Condition 1009 1015;986 996	lesion endodontic
*	OR T31 T32
T33	Condition 1074 1084	edentulous
T34	Qualifier 1063 1073	Completely
R7	Has_qualifier Arg1:T33 Arg2:T34	
T35	Non-query-able 1086 1206	With evident severe atrophy of the alveolar ridge that could preclude an implant placement (e.g. sharp knife edge ridge)
T36	Observation 1226 1242	clenching habits
T37	Observation 1215 1222	bruxism
*	OR T36 T37
T38	Person 1244 1251	Smokers
T39	Observation 1259 1269	cigarettes
T40	Multiplier 1255 1258;1270 1275	> 5 a day
R8	Has_multiplier Arg1:T39 Arg2:T40	
T41	Observation 1286 1293	alcohol
T42	Multiplier 1301 1313	>2 units/day
R9	Has_multiplier Arg1:T41 Arg2:T42	
T43	Non-query-able 1316 1677	Other severe acute or chronic medical or psychiatric condition or laboratory abnormality which may increase the risk associated with trial participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the participant inappropriate for entry into this trial
T44	Post-eligibility 1680 1735	Patients unable or not willing to return for follow-ups
